DR. REDDY S LABORATORIES Stock Context for AI Screening

DR. REDDY S LABORATORIES is a large-cap stock in Healthcare. This page summarizes key screening signals for DR. REDDY S LABORATORIES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive DRREDDY stock page

Price

₹1,349.00

1W return

+0.68%

1M return

+5.75%

3M return

+13.23%

6M return

+11.77%

1Y return

+5.08%

Market cap

₹112,317.04 cr

26.21

2.95

ROE

+11.94%

ROCE

+13.91%

RSI

58.30

Turnover

₹210.66 cr

Why it can matter in screens

Momentum: DRREDDY is above 50DMA, above 200DMA; RSI is 58.30.
Returns: 1D -0.41%, 1W +0.68%, 1M +5.75%, 3M +13.23%, 1Y +5.08%.
Trend levels: 52W high ₹1,375.70, 52W low ₹1,157.20, off high -1.94%.
Liquidity: latest turnover is ₹210.66 cr; volume vs 20D is +0.87%.
Valuation/profitability: PE 26.21, PB 2.95, ROE +11.94%, ROCE +13.91%.
Growth: 3Y sales CAGR +10.96%, 3Y profit CAGR -1.67%.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	7,516.20 cr	863.00 cr	220.90 cr	2.65
2025-12-31	8,726.80 cr	2,158.60 cr	1,209.80 cr	14.53
2025-09-30	8,805.10 cr	2,430.80 cr	1,437.20 cr	16.18
2025-06-30	8,545.20 cr	2,464.20 cr	1,417.80 cr	17.04
2025-03-31	8,506.00 cr	2,526.20 cr	1,593.30 cr	19.12
2024-12-31	8,358.60 cr	2,427.90 cr	n/a	16.96
2024-09-30	8,016.20 cr	2,389.90 cr	n/a	nan
2024-06-30	7,672.70 cr	2,322.90 cr	1,392.00 cr	16.72

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	33,593.30 cr	7,916.00 cr	4,285.00 cr	51.48
2025-03-31	32,553.50 cr	9,667.10 cr	5,654.40 cr	67.89
2024-03-31	27,916.40 cr	8,842.20 cr	5,568.40 cr	67.04
2023-03-31	24,587.90 cr	7,443.10 cr	4,506.70 cr	54.29
2022-03-31	14,887.20 cr	4,508.00 cr	1,623.20 cr	97.58

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	57,934.60 cr	1,536.80 cr	7,734.10 cr	38,045.70 cr
2025-03-31	49,298.90 cr	1,465.40 cr	4,676.60 cr	33,716.60 cr
2024-03-31	38,751.80 cr	710.70 cr	2,002.00 cr	28,055.00 cr
2023-03-31	32,185.40 cr	577.90 cr	1,347.20 cr	23,099.10 cr
2022-03-31	29,282.70 cr	1,485.20 cr	3,384.50 cr	19,052.70 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	5,675.50 cr	1,833.00 cr	n/a
2025-03-31	4,642.80 cr	1,203.00 cr	n/a
2024-03-31	4,543.30 cr	1,799.80 cr	n/a
2023-03-31	5,887.50 cr	4,000.90 cr	n/a
2022-03-31	2,810.80 cr	905.90 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+26.63%	+33.08%	+30.72%	+13.19%	+9.33%	+0.00%
2025-12-31	+26.64%	+33.20%	+30.44%	+13.87%	+9.47%	+0.00%
2025-09-30	+26.64%	+35.52%	+27.98%	+13.31%	+9.61%	+0.00%
2025-06-30	+26.64%	+36.36%	+26.74%	+13.61%	+10.00%	+0.00%
2025-03-31	+26.64%	+37.29%	+25.62%	+12.89%	+10.15%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	453,042.43 cr	39.400236	+14.71%	+12.90%
DIVISLAB	DIVI S LABORATORIES LTD	179,324.04 cr	69.830233	+16.19%	-2.64%
TORNTPHARM	TORRENT PHARMACEUTICALS L	164,701.07 cr	76.144739	+17.18%	+46.47%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	125,861.94 cr	64.267738	+21.03%	+15.71%
CIPLA	CIPLA LTD	115,660.88 cr	29.801362	+11.79%	-3.80%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,515.66 cr	23.036787	+17.93%	+16.76%
LUPIN	LUPIN LIMITED	112,429.39 cr	21.054508	+26.83%	+27.93%
MAXHEALTH	MAX HEALTHCARE INS LTD	105,577.49 cr	73.195199	+14.33%	-16.28%

Try these prompts

Analyze DR. REDDY S LABORATORIES with valuation, momentum and industry peers
Compare DRREDDY with other Healthcare stocks
Show large-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-08. Not investment advice.